Massive COVID drug trial aims to find best antivirals

NCT ID NCT05041907

Recruiting now Knowledge-focused Sponsor: University of Oxford Source: ClinicalTrials.gov ↗

First seen Jan 12, 2026 · Last updated May 13, 2026 · Updated 15 times

Summary

This study tests different COVID-19 treatments in people with mild symptoms to see how quickly they clear the virus from the body. About 3,800 healthy adults aged 18-60 with early COVID-19 will take part. Researchers compare antiviral drugs and antibodies against no treatment to find the most effective options.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Bangplee Hospital
TERMINATED

Mueang Samut Prakan, 10540, Thailand
Faculty of Tropical Medicine, Mahidol University
RECRUITING

Bangkok, 10400, Thailand

Contact Email: •••••@•••••
Laos-Oxford-Mahosot Wellcome Trust Research Unit
RECRUITING

Vientiane, 01000, Laos

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••
Sukraraj Tropical & Infectious Disease Hospital
RECRUITING

Kathmandu, Nepal

Contact Email: •••••@•••••
The Aga Khan University Hospital
TERMINATED

Karachi, Pakistan
Universidade Federal de Minas Gerais
RECRUITING

Minas Gerais, Brazil

Contact Email: •••••@•••••
Vajira hospital
TERMINATED

Bangkok, 10300, Thailand

Conditions

Explore the condition pages connected to this study.

COVID - 19